Biogen Inc
XETRA:IDP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biogen Inc
XETRA:IDP
|
US |
|
Panthera Resources PLC
LSE:PAT
|
UK |
|
P
|
Public Service Enterprise Group Inc
DUS:PSE
|
US |
|
L
|
Legend Oil and Gas Ltd
OTC:LOGL
|
US |
|
U
|
United Plantations Bhd
KLSE:UTDPLT
|
MY |
|
Aluminum Corporation of China Ltd
SSE:601600
|
CN |
|
A
|
American Express Co
SWB:AEC1
|
US |
|
F
|
Fresenius Medical Care AG
XHAN:FME
|
DE |
|
U
|
Unilever PLC
XHAM:UNV0
|
UK |
|
S
|
Stryker Corp
LSE:0R2S
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IDP's stock price target?
Price Target
209.82
EUR
According to Wall Street analysts, the average 1-year price target for 
IDP is 209.82 EUR with a low forecast of 151.49 EUR and a high forecast of 269.99 EUR.
What is the Revenue forecast for Biogen Inc?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 8 years is 2%.
What is the Gross Profit forecast for Biogen Inc?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 3%. The projected CAGR for the next 8 years is 3%.
What is the Operating Income forecast for Biogen Inc?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 6%.
What is the Pre-Tax Income forecast for Biogen Inc?
Projected CAGR
29%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -1%. The projected CAGR for the next 3 years is 29%.
What is the Net Income forecast for Biogen Inc?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 8 years is 14%.